Review
Accepted on 27 Nov 2025
GPR35-Mediated Metabolic Reprogramming Promotes Tumorigenesis in Digestive Cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Type at least 3 characters
9,066 articles
Systematic Review
Accepted on 27 Nov 2025
Survival Benefits of Different Immunotherapies for Hepatocellular Carcinoma: A Meta-Analysis Highlighting Age, Gender, Etiology, and Tumor Burden
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Perspective
Accepted on 27 Nov 2025
Melanoma Vaccines: Current R&D Landscape, Translational Hurdles, and Future Outlook—A Perspective Drawn from 442 Clinical Trials
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 27 Nov 2025
Evaluation of Programmed Cell Death Ligand-1 Expression in Primary Central Nervous System Lymphoma Using Whole-Tumor Histogram Analysis of Multiparametric MRI: Implications for Immunotherapy Selection
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Mini Review
Published on 27 Nov 2025
Current landscape of CAR-therapy for osteosarcoma and rhabdomyosarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1696830
- 406 views
Review
Published on 27 Nov 2025
Application and prospects of ultrasound combined with immunotherapy in cancer treatment of intensive care
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1670527
- 562 views
Original Research
Published on 27 Nov 2025
Unveiling the novel value of TREM1 in the proneural-mesenchymal transition of glioma via tumor-associated macrophages
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1662351
- 139 views
Review
Published on 27 Nov 2025
Synthetic biology approaches to enhance cancer immune responses
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1698158
- 382 views
Original Research
Published on 27 Nov 2025
Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1677361
- 276 views
Original Research
Published on 27 Nov 2025
Inhibition of CRM1 reverses hypoxia-driven chemoresistance in acute myeloid leukemia via overcoming HIF-1α-mediated lysosomal sequestration
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1710230
- 237 views
Review
Published on 27 Nov 2025
Regulatory T cells in cancer: from immunosuppression to therapeutic targeting
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1703211
- 218 views
Original Research
Published on 27 Nov 2025
Integrated multi-omics elucidates PRNP knockdown-mediated chemosensitization to gemcitabine in pancreatic ductal adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1667835
- 113 views
Case Report
Published on 27 Nov 2025
Significant increase in calcification and ossification observed after the second relapse of low-grade myofibroblast sarcoma treated with radiotherapy followed by anlotinib and toripalimab: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1606825
- 147 views
Review
Published on 27 Nov 2025
Comparative pathophysiology and molecular insights into cutaneous and non-cutaneous canine skin cancers: focus on melanoma, mast cell tumors, and squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1624598
- 221 views
Case Report
Published on 27 Nov 2025
Adrenal crisis occurring after the application of immune checkpoint inhibitors in a hepatitis B - related hepatocellular carcinoma patient: case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604740
- 341 views
Original Research
Published on 27 Nov 2025
Pre−treatment cytokines plus TPSA predict biochemical progression−free survival in prostate cancer metastasis and discriminate metastatic status: a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1686570
- 366 views